NDC 60505-0039-01 - Etodolac

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
60505-0039
Requested NDC
60505-0039-01
Package NDCs from labels
60505-0039-1, 60505-0039-01
Manufacturer
Apotex Corp. | Apotex Inc.
Effective date
2026-09-11
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Etodolac Capsules, USP 200 and 300 mg Rx onlyApotex Corp. | Apotex Inc.2026-09-11HUMAN PRESCRIPTION DRUG LABEL
Etodolac - AvKAREAvKARE2024-01-09HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60505-0039-1Etodolac100 in 1 BOTTLECAPSULE10013

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60505-0039ETODOLAC CAPSULE [APOTEX CORP.]12Current NDC, Legacy NDC, 1 package rows20240809_86c7b7b8-3a98-e5f4-c558-5b5caede6377.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60505-0039-1EA - Each60505-0039d7964b66-79ba-4049-a727-42c045c1d78c12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ETODOLACACTIVE INGREDIENT2M36281008ETODOLAC CAPSULE [APOTEX CORP.]2
ETODOLACACTIVE MOIETY2M36281008ETODOLAC CAPSULE [APOTEX CORP.]2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48ETODOLAC CAPSULE [APOTEX CORP.]2
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357ETODOLAC CAPSULE [APOTEX CORP.]2
GELATININACTIVE INGREDIENT2G86QN327LETODOLAC CAPSULE [APOTEX CORP.]2
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XETODOLAC CAPSULE [APOTEX CORP.]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ETODOLAC CAPSULE [APOTEX CORP.]2
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JETODOLAC CAPSULE [APOTEX CORP.]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APETODOLAC CAPSULE [APOTEX CORP.]2
TALCINACTIVE INGREDIENT7SEV7J4R1UETODOLAC CAPSULE [APOTEX CORP.]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPETODOLAC CAPSULE [APOTEX CORP.]2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 136 · 2,713 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HERA SILKYSTAY FOUNDATION 47N1TITANIUM DIOXIDEAmorepacific Corporation5f435148-dcb1-cfdf-e063-6394a90aa8b62026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 50N1TITANIUM DIOXIDEAmorepacific Corporation5f43610f-6c4f-dd9d-e063-6394a90ab60a2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 48N1TITANIUM DIOXIDEAmorepacific Corporation5f4372c4-b87a-91ab-e063-6294a90a68072026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 49C1TITANIUM DIOXIDEAmorepacific Corporation5f4380d1-2cf4-1fd8-e063-6394a90a0aa32026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA BLACK CUSHION FOUNDATION 13N1OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDEAmorepacific Corporation5aff3d25-d034-0815-e063-6294a90a86642026-10-29WarningsExact identifier
unii: 15FIX9V2JP
Blue Lizard Sensitive SPF 50 SunscreenTITANIUM DIOXIDE AND ZINC OXIDECrown Laboratories32d78048-d281-1d80-e063-6394a90aec192026-10-28WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 32W1TITANIUM DIOXIDEAmorepacific Corporation5eed2165-afc2-6958-e063-6294a90add582026-10-28WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 34O1TITANIUM DIOXIDEAmorepacific Corporation5eedd87b-a7b1-1abc-e063-6294a90ae29e2026-10-28WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 26N1TITANIUM DIOXIDEAmorepacific Corporation5ec7151e-4f83-4aca-e063-6294a90a98182026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 26W1TITANIUM DIOXIDEAmorepacific Corporation5ec7276d-fcaf-65b2-e063-6394a90ac2202026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28C1TITANIUM DIOXIDEAmorepacific Corporation5ec73566-5d67-7153-e063-6394a90aba332026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28N1TITANIUM DIOXIDEAmorepacific Corporation5ec75100-153c-80cd-e063-6294a90a6d512026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28O1TITANIUM DIOXIDEAmorepacific Corporation5ec77f7a-4621-ac0c-e063-6294a90a3f702026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 29N1TITANIUM DIOXIDEAmorepacific Corporation5ec7ab15-9cc1-d53a-e063-6294a90a41112026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 29W1TITANIUM DIOXIDEAmorepacific Corporation5ec83b87-08bc-7590-e063-6294a90a0b782026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31C1TITANIUM DIOXIDEAmorepacific Corporation5ec857a3-7fd1-6461-e063-6394a90aacd72026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31N1TITANIUM DIOXIDEAmorepacific Corporation5ec871dc-f74e-765c-e063-6394a90a27a52026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 13N1TITANIUM DIOXIDEAmorepacific Corporation5eb19976-6983-3d9e-e063-6394a90a01ee2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17C2TITANIUM DIOXIDEAmorepacific Corporation5eb338c7-e99c-887d-e063-6394a90a977c2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17N1TITANIUM DIOXIDEAmorepacific Corporation5eb363fe-c2b2-9381-e063-6294a90ad0382026-10-25WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.